ISPOR Europe; A distinctive opportunity at the forefront of great change

In approximately 2 weeks, 3,800 global researchers and thought leaders will be coming together in Amsterdam to explore “New Challenges for Improving European Health Care” at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual European Congress, November 8-12. The conference is a great opportunity for us to interface with clients, partners and peers, as we all face the forefront of great change within our industry.Brian Kelly

At each ISPOR event, I conduct hands-on sessions with our clients in attendance. This work, especially with European colleagues who deal with different health care policies and protocols from those found in the United States, allows us to bring together diverse experiences, perspectives and insights to improve health care globally. Ultimately we hope to improve the overall health care landscape by advancing the quality of research and quickening the speed to market for new technologies.

Optum exists to help our clients frame their problems, to help them solve those problems and to deploy solutions. That’s why our participation at professional societies like ISPOR is important. We have the opportunity to present, participate and witness the important role of real-world data and how it can improve population health around the world.

In Amsterdam Optum is sponsoring two of my colleagues in an educational symposium titled “End of life or end of the road: Are rising cancer costs sustainable?” Monique Martin, PharmD, MSc, MBA, Vice President and General Manager HEOR Europe, Optum, Uxbridge, United Kingdom and Nahila Justo, MPhil, MSc, MBA, Associate Director, Optum, Stockholm, Sweden will be joined by Alistair McGuire, PhD, Professor of Health Economics, London School of Economics and Michael Drummond, DPhil, Professor of Health Economics, University of York to discuss this critical topic. In Western health care, we already know that rising costs associated with treating patients with stage four cancer are increasing beyond a sustainable level. I believe that this symposium will provide great insight into the problem from multiple viewpoints. More importantly, as the syllabus states, “possible solutions to tackle this thorny issue will be provided.”

Researchers and decisions makers attending ISPOR will also have the opportunity to see William H. Crown, PhD, Chief Scientific Officer, Optum Labs and Past President of ISPOR as he participates in a workshop session that will examine the delivery of effective and efficient health care services in complex systems. As an active supporter, participant and leader of ISPOR, Dr. Crown is an effective and dynamic speaker who will be joined on this panel by his peers from The Netherlands; Canada and The United States.

And finally, Optum is presenting 15 posters on a wide variety of important research topics.

If you can’t make the conference this year, I encourage you to engage and participate via social media. Join our Twitter conversation at @OptumNews or follow additional discussions at @ISPORorg and #ISPORAmst.

Brian Kelly, President, Optum Life Sciences

Related Content

For a full schedule of Optum’s contributions, click here.

Leave a Reply